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Striatal cholinergic interneurons are implicated in
motor control, associative plasticity, and reward-
dependent learning. Synchronous activation of
cholinergic interneurons triggers large inhibitory syn-
aptic currents in dorsal striatal projection neurons,
providing one potential substrate for control of stria-
tal output, but the mechanism for these GABAergic
currents is not fully understood. Using optogenetics
and whole-cell recordings in brain slices, we find
that a large component of these inhibitory responses
derive from action-potential-independent disynaptic
neurotransmission mediated by nicotinic receptors.
Cholinergically driven IPSCs were not affected by
ablation of striatal fast-spiking interneurons but
were greatly reduced after acute treatment with
vesicularmonoamine transport inhibitors or selective
destruction of dopamine terminals with 6-hydroxy-
dopamine, indicating that GABA release originated
from dopamine terminals. These results delineate a
mechanism in which striatal cholinergic interneurons
can co-opt dopamine terminals to drive GABA
release and rapidly inhibit striatal output neurons.
INTRODUCTION
While they represent a sparse population of neurons within the
striatum (1%–2%), cholinergic interneurons have been impli-
cated inmultiple striatal functions, includingmotor control, asso-
ciative learning, and reward (Exley andCragg, 2008; Shuen et al.,
2008). Tonically active neurons (TANs), thought to be striatal
cholinergic interneurons (Wilson et al., 1990), show precise pat-
terns of firing during reward-based learning paradigms, suggest-
ing a prominent role in plasticity (Cachope et al., 2012; Hanley
and Bolam, 1997; Shen et al., 2005; Stuber et al., 2010). Although
the precise mechanism by which cholinergic interneurons con-
trol striatal output has not yet been elucidated, recent studies
provide interesting clues.Activation of dorsal striatal cholinergic interneurons drives
inhibitory responses in the principal cells of the striatum, medium
spiny neurons (MSNs) and other cholinergic interneurons
(English et al., 2012; Sullivan et al., 2008; Witten et al., 2010).
Optogenetically evoked inhibitory postsynaptic currents (IPSCs)
have two distinct components: a fast component (fIPSC) with a
decay time constant of approximately 5ms and a slower compo-
nent (sIPSC) with a time constant of about 90 ms (English et al.,
2012). Disynaptic inhibition via a rare striatal GABAergic inter-
neuron subtype, neurogliaform cells, appears to explain a sub-
stantial portion of the sIPSC (English et al., 2012). However,
the source of the fIPSC has not been identified.
In principle, the fIPSC may be monosynaptic or disynaptic. A
disynaptic process would involve first a cholinergic synapse
and then a GABAergic synapse. If disynaptic, two features of
the fIPSC are as yet unclear: (1) whether cholinergic control of
GABA release is mediated by axon-to-dendrite versus axon-to-
axon-terminal neurotransmission, and (2) what cell type releases
GABA. Two cell types are good candidates by virtue of being
activated by nicotinic receptors and their ability to drive large,
fast inhibitory responses in MSNs: fast-spiking interneurons
(FSIs) (Koo´s and Tepper, 2002) and nigrostriatal dopaminergic
neurons (Cachope et al., 2012; Exley and Cragg, 2008; Threlfell
et al., 2012; Zhou et al., 2001). Recent experiments have also
demonstrated that dopaminergic neurons can release both
dopamine and GABA, both of which depend on the vesicular
monoamine transporter (VMAT) (Tritsch et al., 2012).
Here, we test the potential roles of striatal FSIs and dopamine
terminals in mediating cholinergically triggered disynaptic IPSCs
in MSNs. Using a combination of methods, we demonstrate that
the fast portion of the IPSC is mediated by cholinergic activation
of GABA release from striatal dopaminergic terminals, which
is action potential independent. These findings suggest that
cholinergic interneurons are able to rapidly regulate striatal
output throughGABAergic inhibition, while simultaneously exert-
ing neuromodulatory control via dopamine and acetylcholine
signaling.
RESULTS
We used an optogenetic approach to explore how cholinergic
interneuron activity influences striatal output neurons. InjectionNeuron 82, 63–70, April 2, 2014 ª2014 Elsevier Inc. 63
Figure 1. Optogenetic Activation of Striatal Cholinergic Interneu-
rons Elicits Inhibitory Synaptic Responses
(A–D) Dorsal striatal slices from ChAT-Cre mice injected with AAV2/1-DIO-
ChR2-mCherry. (A) Immunohistochemistry for ChAT (top), mCherry (middle),
and merged (bottom), showing mCherry-positive neurons were positive for
ChAT. Scale bar, 100 mm. (B) Left: recording configuration. Current-clamp
recording from an mCherry-positive, putative cholinergic interneuron. Mem-
brane potential responses to injection of ±100 pA (middle) or a single 5 ms light
pulse (470 nM, blue bar; right). (C) Left: recording configuration. Middle:
voltage-clamp recording from amedium spiny neuron (MSN). Blue light pulses
evoked a large inward current with two phases before (black) and after (green)
application of picrotoxin (50 mM). Right: current-clamp recording from anMSN
depolarized to fire action potentials. A blue light pulse caused a brief pause in
the firing of theMSN. (D) Left: recording configuration. Right: synaptic currents
from aD1-Tomato-positiveMSN (red trace) and a nearby D1-Tomato-negative
MSN (black trace) in response to blue light pulses. (E and F) Recordings made
in ChAT-Cre mice injected with AAV5-DIO-eNpHR3.0-YFP. (E) Left: recording
configuration. Right: current-clamp recording from a YFP-positive, putative
cholinergic interneuron, showing hyperpolarization followed by rebound firing
in response to a 1,000 ms light pulse (554 nm, yellow bar). (F) Left: recording
configuration. Right: a large IPSC in an MSN at the offset of the light pulse.
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ing channelrhodopsin-2 (ChR2) in the dorsal striatum of choline
acetyltransferase (ChAT)-Cre mice produced selective ChR2
expression in striatal cholinergic interneurons (Figure 1A).
To physiologically confirm ChR2 expression in cholinergic in-
terneurons, we performed whole-cell current-clamp recordings
of mCherry-positive neurons. These neurons showed typical
intrinsic properties, including spontaneous action potential
firing, pronounced action potential afterhyperpolarization, and
a characteristic voltage sag with hyperpolarizing current (Kawa-
guchi, 1993) (Figure 1B). Brief (5 ms) blue light pulses triggered
action potentials in mCherry-positive putative cholinergic neu-
rons (Figure 1B).
To isolate inhibitory synaptic currents triggered by activation
of cholinergic neurons, we performed whole-cell voltage-clamp
recordings of medium spiny neurons in the presence of gluta-
mate receptor antagonists NBQX and D-APV. Using a high-
chloride internal solution to promote detection of GABAergic
currents, blue light pulses elicited IPSCs measuring 1,830 ±
290 pA (n = 37). This light-evoked IPSC was characterized by
distinct phases of decay, as has been described previously
(English et al., 2012): the fIPSC had a decay time constant of
5.2 ± 1.0 ms, while an sIPSC had a decay time constant of
90 ± 7 ms (Figure 1C). Both IPSC phases were blocked by the
GABAA antagonist picrotoxin (50 mM; 98% ± 0.4% block;
n = 6; p = 0.009; Figure 1C), which was shown previously with
bicuculline (English et al., 2012), confirming that the IPSC is
GABAergic. Delivery of two blue light pulses at short intervals
produced IPSCs with marked paired-pulse depression; full re-
covery of the IPSC occurred between 30 and 60 s (Figure S1
available online). Single blue light pulses could block action
potentials in MSNs under physiological conditions (see example,
Figure 1C), demonstrating the potential functional relevance of
these inhibitory responses. To determine whether light-evoked
IPSCs differed between direct- and indirect-pathway medium
spiny neurons, a subset of experiments were performed in
ChAT-Cre:Drd1a-Tomato mice, which express the fluorescent
reporter tdTomato in dopamine D1 receptor-containing neurons
Figure 2. Disynaptic Inhibitory Synaptic Responses Are Action
Potential Independent
(A) Voltage-clamp recording from an MSN, showing the inward current trig-
gered by carbachol (10 mM), locally pressure ejected from a pipet positioned
nearby (schematic at left). The carbachol-evoked current is shown before
(black) and after (green) bath application of picrotoxin (50 mM; middle) and
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rable in interleaved D1-Tomato-positive and -negative MSNs
(Figure 1D), measuring 990 ± 210 pA (n = 14) and 920 ± 110 pA
(n = 12, p = 0.6), respectively. To determine whether rebound
firing by cholinergic interneurons could also drive IPSCs, the
inhibitory opsin halorhodopsin (eNpHR3.0) was expressed
in cholinergic interneurons. In ChAT-Cre mice injected with
AAV5-DIO-eNpHR3.0-YFP, yellow light caused hyperpolar-
ization of the membrane potential in cholinergic interneurons
and, at the offset of such pulses, rebound spiking (Figure 1E).
Voltage-clamp recordings of MSNs showed large IPSCs at the
offset of yellow light pulses (Figure 1E), which were similar in
amplitude (1,130 ± 230 pA; n = 5) and kinetics (tau decay times
for fast and slow components 6.2 ± 1.5 and 127.6 ± 28.2 ms,
respectively) to IPSCs elicited with ChR2 activation. These find-
ings suggest that cholinergic interneuron activity, triggered by
direct depolarization or rebound following hyperpolarization,
can lead to large IPSCs in MSNs.
Light-evoked IPSCs could, in principle, be derived frommono-
synaptic GABA release by cholinergic interneurons themselves,
as has been shown in the retina (Lee et al., 2010), or through a
disynaptic mechanism (Figure S2). A disynaptic mechanism
should depend on transmitter release from cholinergic interneu-
rons onto a second class of GABA-containing neurons. Indeed,
the fast portion of the IPSC was reconstituted by local applica-
tion of the cholinergic agonist carbachol (10 mM) near the re-
corded MSN. Carbachol produced large-amplitude IPSCs
(850 ± 160 pA, n = 11), which were blocked by picrotoxin
(50 mM; Figure 2A). This carbachol-triggered IPSC had a tau
decay of 7.2 ± 1.1 ms (n = 11) comparable to the fast component
of the light-evoked IPSC, suggesting that local application could
selectively recruit GABA release responsible for the fIPSC.
Carbachol-triggered IPSCs were also blocked by the nicotinic
antagonist mecamylamine (5 mM; Figure 2A), indicating that
they are mediated by nicotinic acetylcholine receptors. Depen-
dence of light-evoked responses on acetylcholine release was
confirmed using cholinergic receptor antagonists. IPSC ampli-
tude was not significantly reduced by the muscarinic antagonist
scopolamine (10 mM; 3% ± 7% block; n = 5; p = 0.39) or the a7
nicotinic receptor antagonist methyllycaconitine (MLA, 10 nM;
15% ± 11% block; n = 7; p = 0.14) but was potently inhibited
by the nicotinic antagonists mecamylamine (5 mM; 97% ± 2%before (black) and after (orange) bath application of the nicotinic antagonist
mecamylamine (5 mM; right). (B) Representative light-evoked inhibitory syn-
aptic responses (schematic at left) before (black) and after application of the
muscarinic antagonist scopolamine (10 mM, red), the nicotinic antagonists
mecamylamine (5 mM, orange) and dihydrobetaerythroidine (DHbE; 10 mM,
green), and the a7 nicotinic antagonist methyllycaconitine (MLA; 10 nM, blue).
Right: normalized IPSC amplitude. (C) Top: light-activated IPSCs in MSNs
(schematic at left). The disynaptic IPSC (black) was abolished by bath appli-
cation of tetrodotoxin (TTX; 1 mM, purple) then partly restored by TTX +
4-aminopyridine (4-AP; 100 mM, red). Right: normalized net IPSC charge.
Bottom: carbachol-evoked IPSCs in MSNs (schematic at left) at baseline
(black) and after TTX (purple) and TTX + 4-AP (red). Right: normalized net IPSC
charge. (D) Carbachol-evoked IPSCs in MSNs at baseline (black trace) and
after application of cadmium chloride (100 mM; left, blue trace) or mibefradil
(100 mM; middle, green trace). Right: normalized IPSC amplitude. All bars
represent mean ± SEM.
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10 mM; 93% ± 3% block; n = 5; p = 0.034; Figure 2B). These
experiments demonstrated that the IPSC depends on non-a7-
containing nicotinic acetylcholine receptors and suggested a
disynaptic mechanism.
Disynaptic IPSCs could derive from cholinergic stimulation
of an action potential in a second neuron, resulting in action-
potential-dependent release of GABA onto MSNs. Alternatively,
acetylcholine could activate nicotinic receptors at sites of GABA
release, eliciting IPSCs in MSNs without a requirement for action
potentials (see Figure S2). To investigate this latter possibility, we
activated cholinergic interneurons and recorded IPSCs in MSNs
while applying the sodium channel antagonist tetrodotoxin (TTX,
1 mM), which would be expected to block action potentials in
both the cholinergic interneuron and putative GABAergic neu-
rons. TTX application resulted in a complete block of the disy-
naptic IPSC (Figure 2C). However, application of TTX together
with the potassium channel antagonist 4-aminopyridine (4-AP,
100 mM), which enables ChR2-mediated release of neurotrans-
mitter without action potentials (Petreanu et al., 2012), partially
restored the IPSC (Figure 2C). The average amplitude of IPSCs
after addition of TTX and 4-AP was 43% ± 11% (n = 14) of the
control IPSC, and the area under the IPSC (net charge) after
addition of TTX and 4-AP was 77% ± 17% of the control IPSC
(n = 14; Figure 2C). Using a similar method, the net charge of
the carbachol-triggered IPSC in the presence of TTX and 4-AP
was 79% ± 16% of control (n = 6; Figure 2C). These results
support the hypothesis that a substantial portion of the IPSC
triggered by cholinergic interneuron stimulation is through an
action-potential-independent mechanism.
Though activation of nicotinic receptors led toGABA release, it
was unclear whether synaptic vesicle release was triggered
directly by calcium influx through nicotinic receptors or through
recruitment of additional calcium sources, such as voltage-
gated calcium channels or internal calcium stores. As optoge-
netically evoked IPSCs were blocked by DHbE but not by
MLA, the nicotinic receptors involved are a non-a7-containing
subtype, with lower calcium permeability (Rice and Cragg,
2004), and are thus less likely to participate directly in vesicle
fusion. Suspecting voltage-gated calcium channels might pro-
vide the necessary calcium, we elicited IPSCs with pressure-
ejected carbachol and applied cadmium chloride, a nonselective
blocker of voltage-gated calcium channels that does not block
a4-containing nicotinic receptors (Karadsheh et al., 2004).
Cadmium markedly reduced IPSC amplitude (n = 5; p = 0.01;
Figure 2D), suggesting voltage-gated calcium channels are
required for nicotinic activation of GABA release. In the hippo-
campus, nicotinic depolarization of axon terminals triggers
GABA release through T-type calcium channels (Tang et al.,
2011), so we proceeded to test the role of these channels in
light-evoked disynaptic inhibition. The specific T-type calcium
channel blocker mibefradil (5 mM) reduced the light-evoked
IPSC by 41% ± 6% (n = 8, p = 0.02; data not shown) and the
carbachol-evoked IPSC by 67% ± 3% (n = 4; Figure 2D).
Together, these results suggest that presynaptic nicotinic recep-
tor activation leads to the recruitment of voltage-gated calcium
channels, including T-type channels, to cause sufficient calcium
influx for release of GABA onto MSNs.66 Neuron 82, 63–70, April 2, 2014 ª2014 Elsevier Inc.While these findings suggest that the fIPSC triggered by acti-
vation of cholinergic interneurons is likely to be disynaptic and
action potential independent, they do not indicate which neurons
release GABA. FSIs drive large inhibitory synaptic responses in
MSNs, making them a candidate source of GABA for the fast
disynaptic ISPC (Gittis et al., 2010; Koo´s and Tepper, 1999).
To determine whether FSIs are required for disynaptic inhibition,
we selectively ablated amajority of the parvalbumin (PV)-positive
FSIs by injecting the striatum of PV-Cre mice (Figure 3A) with a
Cre-dependent virus encoding pro-caspase-3 and an enzyme
that cleaves pro-caspase-3 into the active, proapoptotic signal
caspase-3 (Yang et al., 2013). PV-positive cells were greatly
diminished in the AAV-FLEX-taCasp3-TEVp-injected striatum
as compared to the contralateral control striatum (3 ± 1 versus
56 ± 6 PV-positive dorsal striatal neurons per section; n = 7
mice; Figures 3B and 3C). As a positive control that this manip-
ulation could eliminate monosynaptic inhibition from FSI onto
MSN, we injected PV-Cre mice with bilateral AAV1-DIO-ChR2-
YFP and unilateral AAV1-FLEX-taCasp3-TEVp. Slices contralat-
eral to AAV1-FLEX-taCasp3-TEVp injection showed expression
of ChR2-YFP in PV-positive putative FSI (Figure S3B), while in
ipsilateral slices very few PV-positive neurons were detected
(Figures 3B, 3C, and S3A); most of these remaining neurons
expressed ChR2-YFP. Presumed monosynaptic FSI-mediated
IPSCs were large in control slices (5,880 ± 530 pA; n = 7) but
negligible in caspase-treated slices (30 ± 8 pA; n = 13, n = 3
mice; p = 0.0001; Figure 3C), demonstrating that near-complete
elimination of PV neurons resulted in near-complete loss of the
FSI-mediated IPSC in MSNs. To determine whether elimination
of PV-positive neurons and their input onto MSNswould likewise
reduce the disynaptic IPSCderived from activation of cholinergic
interneurons, we injected AAV1-FLEX-taCasp3-TEVp unilater-
ally in ChAT-ChR2::PV-Cre mice. In these mice, ChR2 is ex-
pressed constitutively in cholinergic interneurons (Zhao et al.,
2011). Interestingly, ablation of PV-positive neurons (Figures
3B and 3D) did not significantly alter light-evoked disynaptic
IPSCs (1,110 ± 370 pA; n = 18 neurons/n = 4 mice in the injected
hemisphere versus 960 ± 340 pA; n = 13 neurons/n = 4 mice in
the untreated hemisphere; p = 0.79; Figure 3D). These results
demonstrate that FSIs are not required for disynaptic IPSCs
and suggest that the majority of the fIPSC is derived from an
alternate source of GABA.
Given that (1) optogenetic activation of cholinergic interneu-
rons can drive terminal dopamine release in the striatum
(Cachope et al., 2012; Threlfell et al., 2012), and (2) anatomical
studies (Campbell et al., 1991; Gonza´lez-Herna´ndez et al.,
2001) and a recent physiological study (Tritsch et al., 2012) sug-
gest striatal dopaminergic axon terminalsmay release GABA, we
hypothesized that the fIPSCwas derived from cholinergic activa-
tion of dopaminergic axon terminals, resulting in GABA release.
To test this hypothesis, we compared disynaptic IPSCs in slices
from animals treated unilaterally with saline (control) or the dopa-
minergic neurotoxin 6-hydroxydopamine (6-OHDA). Degenera-
tion of dopaminergic axons ipsilateral to the injection was
confirmed by post hoc tyrosine hydroxylase staining (Figure 4A).
6-OHDA treatment resulted in markedly reduced light-evoked
IPSCs (170 ± 40 pA, n = 14 neurons/n = 4 mice) as compared
to saline treatment (Figures 4B and 4C; 1,610 ± 410 pA, n = 10
Figure 3. Ablation of Parvalbumin-Positive Fast-Spiking Interneu-
rons Does Not Alter the Disynaptic IPSC
The dorsolateral striatum of PV-Cre mice was injected with AAV1-FLEX-
taCasp3-TEVp to ablate parvalbumin (PV)-positive neurons. (A) Top: diagrams
of the brain in sagittal view (left), showing the area of viral injection, and coronal
view (right), showing the structures in histological sections below. (B) Coronal
sections immunostained for PV (red). Top: control (uninjected) hemisphere
(left) and hemisphere injected with AAV1-FLEX-taCasp3-TEVp (right). Scale
bar, 1 mm. Inset: area of dorsal striatum where physiological recordings were
made. Bottom: control (uninjected, left) and FSI-ablation (injected, right) sec-
tions, showing striatal PV-positive neurons. Scale bar, 150 mm. (C) Recordings
made from PV-Cre mice injected with bilateral AAV1-DIO-ChR2-YFP and
unilateral AAV1-FLEX-taCasp3-TEVp. Top left: recording configuration. Top
right: average number of PV-positive neurons per hemisection of the dorsal
striatum in control (ChR2 only) and FSI ablation (ChR2 + caspase) conditions.
Bottom left: representative light-activated (presumed monosynaptic) currents
elicited in MSNs in the control (black) and FSI ablation (blue) conditions.
Bottom right: average IPSC amplitude in control versus FSI ablation slices. (D)
Recordings made from PV-Cre:ChAT-ChR2 mice injected with unilateral
AAV1-FLEX-taCasp3-TEVp. Top left: recording configuration. Top right:
average number of PV-positive neurons per hemisection of the dorsal striatum
in control and FSI ablation conditions. Bottom left: representative light-
activated (presumed disynaptic) currents in MSNs in control (black) and FSI
ablation (blue) conditions. IPSCs recorded at70mV in the presence of NBQX
and APV. Bottom right: average IPSC amplitude in control versus FSI ablation
slices. All bars represent mean ± SEM.
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fIPSC triggered by activation of cholinergic interneurons de-
pends on the integrity of nigrostriatal dopamine neurons. To
further investigate whether depletion of neurotransmitter from
dopamine terminals alters IPSC amplitude, we compared disy-
naptic IPSCs in slices from mice treated with the VMAT inhibitor
reserpine and interleaved control mice. Although a provocative
finding, a prior study showed that inhibition of VMAT prevented
dopamine and GABA release from striatal dopamine terminals
(Tritsch et al., 2012). We found markedly reduced IPSC ampli-
tudes in reserpine-treated mice (240 ± 40 pA, n = 19; n = 3
mice) compared to interleaved control mice (Figures 4B and
4C; 1,760 ± 90 pA, n = 14; n = 5 mice; p = 0.0001), indicating
that IPSCs depend on VMAT. Surprisingly, 6-OHDA and reser-
pine treatment resulted in reductions of both fast and slow
IPSC components: neuropeptide Y-expressing neurogliaform
(NPY-NGF) neurons contribute prominently to the sIPSC (English
et al., 2012). Suspecting that the chronicity of 6-OHDA and reser-
pine treatment might lead to striatal microcircuit reorganization
and downregulation of the NPY-NGF-mediated sIPSC, we next
used the more rapid-acting VMAT inhibitors Ro4-1284 and tetra-
benazine (TBZ). These two agents were administered either
in vivo immediately before slicing (Ro4-1284) or ex vivo to slices
(TBZ). Acute Ro4-1284 treatment also reduced the amplitude of
disynaptic IPSCs (670 ± 170 pA; n = 13 neurons/n = 2 mice) as
compared to Ro4-1284 treatment followed by artificial cerebro-
spinal fluid (ACSF) wash for at least 1 hr (Figures 4B and 4C;
1,840 ± 360 pA; n = 12 neurons/n = 2 mice; p = 0.006) but left
a substantial residual sIPSC. TBZ treatment decreased IPSC
amplitude (740 ± 130 pA; n = 7 neurons/n = 3 mice) compared
to interleaved controls (Figures 4B and 4C; 2,570 ± 770 pA;
n = 9 neurons/n = 3 mice; p = 0.04), also leaving a residual
sIPSC (decay tau 152 ± 26 ms). To verify that the decreased
amplitude of IPSCs was not due to loss of dopamine-mediatedNeuron 82, 63–70, April 2, 2014 ª2014 Elsevier Inc. 67
Figure 4. Disynaptic Inhibitory Responses Require Dopaminergic
Neurons
(A) Coronal sections containing the striatum immunostained for tyrosine hy-
droxylase (red). Left: striatum of mouse injected with saline. Right: striatum of
mouse injected with 6-OHDA. Scale bar, 1 mm. (B) Recording configuration.
Representative light-evoked currents in MSNs from ChAT-Cre animals in-
jected with striatal AAV2/1-DIO-ChR2-mCherry. IPSCs are shown at baseline
(black) versus after 10 min application of SCH23390 (1 mM) and sulpiride
(10 mM, blue); in slices from saline-injected (black) versus 6-OHDA-injected
(purple) mice; interleaved control (black) versus reserpine-injected (red) mice;
Ro4-1284-incubated (orange) versus Ro4-1284 washout (black) slices from
the same Ro4-1284-injected mice; and tetrabenazine-treated (green) versus
interleaved control (black) mice. (C) Summary of light-evoked IPSCs. (D)
Schematic diagram of proposed microcircuit involving striatal cholinergic in-
terneurons (red), nigrostriatal dopamine terminals (blue), and medium spiny
neuron dendrites (yellow). All bars represent mean ± SEM.
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and D2 dopamine receptor antagonists (SCH23390, 1 mM; sul-
piride, 10 mM) to control slices. Dopamine antagonists did not
significantly alter IPSC amplitude (Figure 4B; 94% ± 8% of con-
trol, n = 6; p = 0.54). Together, these findings strongly suggest
that dopaminergic terminals provide a major source of the
GABA underlying fast disynaptic IPSCs seen in MSNs after stim-
ulation of cholinergic interneurons, as schematized in Figure 4D.
DISCUSSION
We have demonstrated that optogenetic activation of striatal
cholinergic neurons triggers a disynaptic inhibitory synaptic
response in MSNs, mediated in large part by nicotinic activation
of GABA release from dopamine terminals. Surprisingly, parval-
bumin-positive FSIs, a major source of GABAergic inputs to
MSNs, are not required. As this phenomenon is TTX insensitive,
and axons are the only portion of dopamine neurons present in
our preparation, acetylcholine appears to trigger striatal GABA
release via an action-potential-independent axoaxonic mecha-
nism. These findings link prior studies showing (1) inhibitory re-
sponses in MSNs driven by optogenetic activation of striatal
cholinergic interneurons, (2) inhibitory responses in MSNs driven
by optogenetic activation of striatal dopamine terminals, and (3)
dopamine release driven by optogenetic activation of striatal
cholinergic interneurons and provide a mechanism by which
striatal cholinergic interneurons may potently influence striatal
output by dual control of dopamine and GABA release.
One potential caveat of our study and others using BAC trans-
genic animals for optical control of cholinergic neurons is that
ChAT-ChR2 mice have recently been found to have elevated
ACh release and cognitive deficits due to overexpression of
vesicular ACh transporters (Kolisnyk et al., 2013). Increased
ACh release may enhance the amplitude of ACh-dependent re-
sponses but is unlikely to alter the overall mechanisms that we
have outlined.
The finding that fast GABAergic currents in MSNs derive from
dopamine terminals is intriguing. Though dopamine axon termi-
nals do not always form traditional tight axodendritic synapses
ontoMSNs (Descarries et al., 1996), they do form a relatively uni-
form and dense lattice of inputs in the dorsal striatum (Hanley
and Bolam, 1997), and dopamine may influence postsynaptic
targets over a broad area encompassing tens of thousands of
Neuron
ACh Drives GABA Release from Striatal DA Terminalssynapses (Rice and Cragg, 2008). Terminal GABA release may
also operate via volume transmission or, alternatively, the IPSCs
we observe may arise from GABA release at dopamine terminals
that are located proximal to GABAergic synapses.
Optogenetics provide a tool for synchronous selective activa-
tion of striatal cholinergic interneurons, but prior anatomical and
physiological studies have outlined much of the signaling sub-
strate. Nicotinic acetylcholine receptors reside on dopaminergic
axon terminals (Jones et al., 2001; Threlfell et al., 2010),
providing the anatomical means for acetylcholine to drive the
release of dopamine (andGABA) from axon terminals in the stria-
tum. In addition, the regulation of dopamine release by nicotinic
receptors has been demonstrated directly (Rice and Cragg,
2004; Zhang and Sulzer, 2004; Zhou et al., 2001). These studies
have shown that while phasic cholinergic stimulation can cause
dopamine release, more prolonged stimulation results in nico-
tinic receptor desensitization and reduced release, which may
be responsible for many of the behavioral pharmacology results
obtained with nicotinic agents in vivo. By allowing precisely
timed, synchronous release of acetylcholine and subsequent
stimulation of nicotinic receptors, optogenetic strategies have
facilitated detecting phasic responses in the striatum, which
appear to be opposite in polarity to those seen with more tonic
manipulations of acetylcholine.
Despite evidence that cholinergic signaling is critical for striatal
behaviors, how cholinergic interneurons alter striatal output is
unclear. Spontaneously firing cholinergic interneurons receive
strong excitatory thalamic input, which carries cue-related infor-
mation, and inhibitory inputs from midbrain GABAergic neurons
(Brown et al., 2012). In many in vivo studies, cholinergic neurons
display a burst-pause-burst pattern of firing during relevant cues
in the context of learned tasks. Cholinergic neurons send their
projections widely throughout the striatum, influencing most
striatal neurons through muscarinic or nicotinic receptors. Nico-
tinic receptor activation may have distinct phasic and tonic
effects on MSNs due to the prominent desensitization of many
nicotinic subtypes. The stereotyped burst-pause-burst firing
pattern of cholinergic neurons could allow for (1) a window of re-
lief from desensitization and (2) a more concerted modulation of
MSN firing by release of fast-acting GABA and longer-acting
dopamine during the burst. Afterward, spontaneous firing of
cholinergic interneurons could again result in nicotinic desensiti-
zation and reduced dopamine and GABA release. These same
processesmay also influence the cholinergic interneurons them-
selves, given theproximity of dopamine terminals andcholinergic
interneurons.While the significanceof eachof thesemechanisms
to the function of striatal cholinergic interneurons in vivo is not yet
known, the ability of these neurons to recruit both dopamine and
GABA release to modulate striatal output is likely to significantly
contribute to their influence of basal ganglia function.
EXPERIMENTAL PROCEDURES
Detailed methods are in Supplemental Experimental Procedures.
Animals
Hemizygous ChAT-Cre mice (line GM60, GENSAT) were bred against either
wild-type C57Bl/6 mice (The Jackson Laboratory) or Drd1a-tdTomato mice
(Nicole Calakos, Duke University) to yield ChAT-Cre or ChAT-Cre:Drd1a-tdTomato mice. Hemizygous ChAT-ChR2 mice (The Jackson Laboratory)
were crossed to Parvalbumin-2A-Cre mice (The Jackson Laboratory) to yield
ChAT-ChR2:PV-Cre mice. Mice of either sex were used.
Surgery
Virus was stereotactically injected in the dorsal striatum of mice through a
small hole in the skull. Mice returned to their home cages for 2–4 weeks prior
to histology or physiology. Some mice were later reanesthetized and injected
with either the toxin 6-hydroxydopamine or normal saline in the medial fore-
brain bundle.
Physiology
Mice were deeply anesthetized prior to removing the brain and preparing
300 mmcoronal slices. Slices were stored in carbogenated ACSF at room tem-
perature (RT) and then transferred to a recording chamber superfused with
carbogenated ACSF at 31C–33C. Neurons were patched in the dorsal stria-
tum in whole-cell mode, and ChR2 or eNpHR3.0 was activated with light
pulses delivered through the microscope objective. With the exception of
carbachol, which was pressure ejected from a glass pipet, drugs were admin-
istered in the circulating ACSF.
Histology
A subset of mice was deeply anesthetized, perfused, and fixed. Brains were
removed, cryoprotected, frozen, and cut into 30 mm coronal sections. Primary
antibody (Millipore AB144P Anti-ChAT 1:500, SWANT Anti-parvalbumin
1:1,000, or Pel-Freez P40101 Anti-Tyrosine Hydroxylase 1:1,000) was added
in 5% NDS, 1% Triton in PBS and incubated overnight at 4C. After washing,
slices were incubated with Alexa Fluor 649-conjugated donkey anti-goat or
donkey anti-rabbit secondary antibody (Invitrogen) for 2 hr at RT.
Statistics
All data are presented as the mean ± SEM. Comparisons were made using the
Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2014.01.023.
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